Harmony Biosciences Holdings (HRMY) Return on Equity [ROE] (2020 - 2026)
Harmony Biosciences Holdings (HRMY) posted Return on Equity [ROE] of 18.99% for Q2 2026, down 5.24 percentage points from 24.22% a year earlier but up 2.63 percentage points from the prior quarter.
Powered by 
Analysis
Harmony Biosciences Holdings (HRMY) Return on Equity [ROE] (2020 - 2026) Analysis & Trends
For FY2025, Harmony Biosciences Holdings' Return on Equity [ROE] came in at 20.75%, down 5.09 percentage points from FY2024.
- Annual Return on Equity [ROE] has declined for three consecutive years, with a four-year change of -3.64 percentage points (FY2021 to FY2025).
- In prior years, Harmony Biosciences Holdings' Return on Equity [ROE] was 25.84% in FY2024 (-3.79 pp), 29.63% in FY2023 (-31.96 pp), 61.58% in FY2022 (+37.19 pp) and 24.39% in FY2021.
- Quarterly Return on Equity [ROE] has run from a low of 8.38% in Q3 2021 to a high of 52.73% in Q3 2022 over five years.
- On a year-over-year basis, Return on Equity [ROE] has declined in each of the last three quarters, with an average year-over-year change of -3.90 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q4 2021, with a gain of 58.98 percentage points; the weakest was Q3 2023, with a drop of 21.54 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was 16.36% (Q1 2026), 18.61% (Q4 2025) and 23.09% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Harmony Biosciences Holdings | 2.28 Bn | -474.81 Mn | 198.08 Mn | 18.99% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.99% |
| Mar 31, 2026 | 16.36% |
| Dec 31, 2025 | 18.61% |
| Sep 30, 2025 | 23.09% |
| Jun 30, 2025 | 24.22% |
| Mar 31, 2025 | 22.14% |
| Dec 31, 2024 | 23.17% |
| Sep 30, 2024 | 21.60% |
| Jun 30, 2024 | 21.82% |
| Mar 31, 2024 | 28.03% |
| Dec 31, 2023 | 27.17% |
| Sep 30, 2023 | 31.20% |
| Jun 30, 2023 | 43.14% |
| Mar 31, 2023 | 44.80% |
| Dec 31, 2022 | 48.60% |
| Sep 30, 2022 | 52.73% |
| Jun 30, 2022 | 25.21% |
| Mar 31, 2022 | 24.29% |
| Dec 31, 2021 | 20.44% |
| Sep 30, 2021 | 8.38% |
API Access
Harmony Biosciences Holdings Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=HRMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "HRMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=HRMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();